Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy.
Department of Medicine, University College London Hospitals NHS Foundation Trust and Cardiometabolic Programme-NIHR UCLH/UCL BRC, London, UK.
J Thromb Haemost. 2020 Sep;18(9):2400-2407. doi: 10.1111/jth.14946.
Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, presents with multiple clinical and laboratory manifestations. In this International Society on Thrombosis and Haemostasis (ISTH) communication, we examined the importance of identifying the underlying disorder causing DIC to help physicians in the diagnosis and management of this common and severe condition.
Eight DIC experts participated in a three-step consensus process that searched for published guidelines and diagnostic scores on DIC to create a preliminary list of DIC underlying disorders from those reported in the literature Overall, 13 papers were identified, including three guidelines, one harmonization paper by the ISTH, one ISTH recommendation paper on cancer-associated DIC, five general diagnostic scores, two scores specific for pregnancy, and one specific for children. We then assessed the strength of the evidence on the association between the disease and DIC as many postulated DIC-associated disorders are rare.
Eight main subgroups - 'severe infection', 'solid tumour', 'haematological neoplasia', 'pregnancy complication', 'vascular disease', 'newborn-complication', 'tissue damage due to internal or external insult', and 'chemical and biological agent' - and a detailed list of specific causes of DIC were provided.
CONCLUSIONS & INFERENCES: Our results suggest more data are needed to determine the association between DIC and specific diseases such as malignant lymphoma, colorectal cancer, or vasculitis, for which the evidence remains limited. When a patient develops a coagulopathy consistent with DIC, the first step is to immediately search for an underlying disorder, including specific causes that are rarely associated with DIC and to consider that patients may have more than one cause of DIC to identify the principal precipitating disorder to prioritize treatment.
弥散性血管内凝血(DIC)是一种全身性凝血激活,具有多种临床和实验室表现。在本次国际血栓与止血学会(ISTH)交流中,我们探讨了确定导致 DIC 的潜在疾病的重要性,以帮助医生诊断和治疗这种常见且严重的疾病。
8 名 DIC 专家参与了一个三步骤的共识过程,该过程搜索了关于 DIC 的已发表指南和诊断评分,以根据文献中报告的情况,从这些评分中创建一个潜在 DIC 疾病的初步清单。总共确定了 13 篇论文,包括 3 项指南、ISTH 协调的一篇论文、ISTH 关于癌症相关 DIC 的一份推荐报告、5 种一般诊断评分、2 种针对妊娠的评分和 1 种针对儿童的评分。然后,我们评估了疾病与 DIC 之间关联的证据强度,因为许多假定的 DIC 相关疾病是罕见的。
提供了 8 个主要亚组 - “严重感染”、“实体瘤”、“血液系统恶性肿瘤”、“妊娠并发症”、“血管疾病”、“新生儿并发症”、“内部或外部损伤导致的组织损伤”和“化学和生物制剂” - 以及 DIC 的具体病因的详细清单。
我们的结果表明,需要更多的数据来确定 DIC 与恶性淋巴瘤、结直肠癌或血管炎等特定疾病之间的关联,对于这些疾病,证据仍然有限。当患者出现符合 DIC 的凝血异常时,第一步是立即寻找潜在疾病,包括与 DIC 很少相关的特定病因,并考虑患者可能有不止一种导致 DIC 的原因,以确定主要诱发疾病,从而确定治疗的重点。